Stock IP INTER PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

News Inter Pharma

Equities

IP

TH9474010005

End-of-day quote Thailand S.E.
Other stock markets
 06:00:00 2024-06-09 pm EDT 		5-day change 1st Jan Change
5.05 THB 0.00% Intraday chart for Inter Pharma -1.94% -8.82%
May. 14 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 26 Inter Pharma Public Company Limited Approves Dividend for the Year 2023, Payable on May 24, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Inter Pharma Public Company Limited Approves Dividend for the Year 2023, Payable on May 24, 2024
CI
Inter Pharma Public Company Limited (SET:IP) agreed to acquire 70% stake in Metta Medtech Company Limited from Sittisak Phanitpotchaman for THB 130 million.
CI
Inter Pharma Public Company Limited Proposes Dividend for the Year 2023, Payable on May 24, 2024
CI
Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Inter Pharma Public Company Limited Announces Resignation of Mrs. Nattarin Polpuech as Director, Member of Risk Management Committee and Member of the Executive Committee
CI
Inter Pharma Public Company Limited Announces CFO Changes
CI
Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Inter Pharma Public Company Limited Approves Dividend for the Year 2022, Payable on May 26, 2023
CI
Inter Pharma Public Company Limited Approves Board Changes
CI
Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Inter Pharma Public Company Limited Announces Resignation of Terdkiat Prommool as Director
CI
Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Inter Pharma : New shares of IP to be traded on August 18, 2022
PU
Inter Pharma Public : Notification on Change of Directors and Authorization of Directors
PU
Inter Pharma Public : Report on the results of sale of common shares offered to private placement (F53-5)
PU
Inter Pharma Public : Right Adjustment of IP-W1 (Edited)
PU
Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IP Stock
  4. News Inter Pharma